Serena Desideri Selected Research

talampanel

4/2010	Survival of patients with newly diagnosed glioblastoma treated with radiation and temozolomide in research studies in the United States.
9/2009	Talampanel with standard radiation and temozolomide in patients with newly diagnosed glioblastoma: a multicenter phase II trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Serena Desideri Research Topics

Disease

11	Glioma (Gliomas) 03/2017 - 08/2008
10	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 04/2008
6	Neoplasms (Cancer) 03/2017 - 04/2008
6	Brain Neoplasms (Brain Tumor) 03/2017 - 03/2009
2	Thrombocytopenia (Thrombopenia) 01/2019 - 11/2012
2	Disease Progression 10/2010 - 09/2009
1	Gastritis 01/2019
1	Exanthema (Rash) 01/2019
1	Bradycardia 01/2017
1	Hypertension (High Blood Pressure) 01/2017
1	Hypoxia (Hypoxemia) 04/2012
1	Acidosis 04/2012
1	Infections 08/2011
1	Hyperglycemia 03/2009
1	Rhinitis 08/2008
1	Fatigue 08/2008
1	Astrocytoma (Pilocytic Astrocytoma) 08/2008
1	Edema (Dropsy) 08/2008

Drug/Important Bio-Agent (IBA)

11	Temozolomide (Temodar)FDA LinkGeneric 01/2019 - 03/2009
2	iniparibIBA 01/2019 - 10/2015
2	GlucocorticoidsIBA 08/2011 - 03/2009
2	poly ICLCIBA 10/2010 - 04/2010
2	talampanelIBA 04/2010 - 09/2009
1	EnzymesIBA 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	Biological ProductsIBA 03/2017
1	alovudineIBA 03/2017
1	fms-Like Tyrosine Kinase 3IBA 01/2017
1	tyrosine receptor (receptor, tyrosine)IBA 01/2017
1	tandutinibIBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Alanine Transaminase (SGPT)IBA 01/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	Phosphotransferases (Kinase)IBA 01/2017
1	Platelet-Derived Growth FactorIBA 01/2017
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2017
1	T-Type Calcium Channels (T-Type Calcium Channel)IBA 01/2017
1	MibefradilIBA 01/2017
1	2,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA 12/2016
1	Bevacizumab (Avastin)FDA Link 12/2016
1	Cytotoxins (Cytolysins)IBA 10/2015
1	ProdrugsIBA 10/2015
1	Factor VIII (Coagulation Factor VIII)IBA 09/2015
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2014
1	Vorinostat FDA Link 11/2012
1	terameprocolIBA 04/2012
1	Excipients (Suspending Agents)IBA 04/2012
1	ixabepilone (BMS 247550)FDA Link 11/2010
1	Lysine (L-Lysine)FDA Link 10/2010
1	Poly I-CIBA 10/2010
1	Bortezomib (Velcade)FDA Link 10/2010
1	Carboxymethylcellulose Sodium (Polycell)FDA Link 10/2010
1	CilengitideIBA 04/2010
1	AMPA Receptors (AMPA Receptor)IBA 09/2009
1	Endothelin A ReceptorIBA 08/2008
1	AtrasentanIBA 08/2008
1	Phenytoin (Dilantin)FDA LinkGeneric 04/2008
1	Celecoxib (Celebrex)FDA Link 04/2008
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 04/2008

Therapy/Procedure

7	Therapeutics 01/2017 - 08/2008
4	Radiotherapy 01/2019 - 10/2010
1	Aftercare (After-Treatment) 03/2017
1	Oral Administration 01/2017
1	Drug Therapy (Chemotherapy) 10/2015